Back
Palisade Bio Vs. Equifax Industry Stock Comparison
Sell
47
PALI
Palisade Bio
Last Price:
7.33
Seasonality Move:
-16.46%
Buy
61
EFX
Equifax
Last Price:
224.64
Seasonality Move:
3.45%
Sell
47
Palisade Bio (PALI)
is a Sell
Is Palisade Bio a Buy, Sell or Hold?
- The current Palisade Bio [PALI] share price is $7.28. The Score for PALI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PALI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Equifax (EFX)
is a Buy
Is Equifax a Buy, Sell or Hold?
- The current Equifax [EFX] share price is $224.50. The Score for EFX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- EFX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PALI Stock Price Chart
What is Palisade Bio's stock price today?
-
The Palisade Bio share price today is $7.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PALI is experiencing slight buying pressure.
PALI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 62.27 | Buy |
| Chaikin Money Flow: | 74764 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.92 - 6.48) | Buy |
| Bollinger Bands (100): | (5.41 - 8.53) | Buy |
EFX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.02 | Sell |
| Relative Strength Index (14 RSI): | 37.76 | Sell |
| Chaikin Money Flow: | 417413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (222.57 - 255.59) | Sell |
| Bollinger Bands (100): | (235.19 - 262.33) | Sell |
PALI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.38 | Buy |
| 20-day SMA: | 5.67 | Buy |
| 50-day SMA: | 5.76 | Buy |
| 200-day SMA: | 9.77 | Sell |
| 8-day EMA: | 6.4 | Buy |
| 20-day EMA: | 5.97 | Buy |
| 50-day EMA: | 6.09 | Buy |
| 200-day EMA: | 24.05 | Sell |
EFX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 223.84 | Buy |
| 20-day SMA: | 234.26 | Sell |
| 50-day SMA: | 251.71 | Sell |
| 200-day SMA: | 221.63 | Buy |
| 8-day EMA: | 224.31 | Buy |
| 20-day EMA: | 232.49 | Sell |
| 50-day EMA: | 242.51 | Sell |
| 200-day EMA: | 230.53 | Sell |
Palisade Bio Earnings Growth & PALI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.73 per share, and an increase next year of $3.45 per share.
Equifax Earnings Growth & EFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.
Palisade Bio Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Equifax Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||